News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solasia Pharma K.K. to Start China Clinical Trial of Anti-Nausea Patch Product


2/5/2013 1:58:08 PM

by Richard Daverman, PhD

February 5, 2013 -- Solasia, a Japan-headquartered company, has received a Clinical Trial Permit from the SFDA for China trials of Sancuso®, the company’s transdermal patch product for the treatment of chemotherapy-induced nausea and vomiting. Solasia in-licensed rights to Sancuso® for Southeast Asia in 2008 from a British pharma, ProStrakan. Solasia will begin a trial of the product immediately and expects to file a New Drug Application in China during Q4 of 2013. More details....


Read at ChinaBio Today


comments powered by Disqus
   
Nausea

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES